Kenya Oncology Market Analysis


  • Type: Therapeutics Area
  • Published : June 2021
  • Region: Africa
  • Country: Kenya
  • Report ID : 4823

  • Format: PPT, PDF

Kenya Oncology Drug Market: Segmented by Indication (Breast Cancer, Cervix Uteri Cancer, Prostate Cancer, Lung Cancer, Oesophagus Cancer, Colorectal Cancer, Blood Cancer, Non-Hodgkin lymphoma, Stomach Cancer, Ovarian Cancer and others), Drug Class (Chemotherapy, Immunotherapy, Targeted Therapy, Hormone Therapy and Other Drug Classes) and Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online and Others)- Growth, Trends, and Forecasts (2019 – 2028)


SKU: 4823 Categories: ,

Report Overview

The Oncology Drug market size in Kenya stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

In Kenya, Cancer is the third leading cause of death after infectious diseases and cardiovascular diseases. The annual incidence of cancer in Kenya is about 28 000 new cases with an annual mortality of 22 000 cases, that is, 78.5% of the victims do not survive. The five most common cancer in Kenya are Breast, Cervical, Prostate, Oesophagus and Colorectal Cancer. The leading cause of deaths among females is Cervical cancer followed by Breast cancer and among males is Prostate cancer followed by Oesophagus cancer. The rising incidence of cancer in Kenya may be attributed to increase in the ageing population, adoption of unhealth lifestyles, tobacco and alcohol consumption and physical inactivity. Some chronic infections are risk factors for cancer, in low- and middle-income countries. These carcinogenic infections are caused by Helicobacter pylori, Human papillomavirus (HPV), Hepatitis B virus, Hepatitis C virus, and Epstein-Barr virus.

Market Drivers

The market is majorly driven by the rising incidence of cancer cases in Kenya, which is the primary reason for growth in the Oncology Drug market. As the burden of cancer cases increase in the young population due to increase in the risk factors, need for therapies like Immunotherapy and Targeted Therapy emerge.

Increasing levels of awareness related to early diagnosis and screening of breast and cervical cancers in females and available therapies are leading to a high growth of Oncology Drug.

Increase and an improvement in the diagnostic capabilities in the country will propel growth in the oncology Drug market in Kenya in the forecasted period.

However, the side effects caused by Chemotherapy and Immunotherapy are restraining market growth. Some of the products are withdrawn from the market due to serious side effects. Other restraints of market growth include high cost of treatment and oncology Drug. The National Hospital Insurance Fund (NHIF) provides only 25,000 Kenyan Shillings per patient towards cancer care.

1. Kenya Oncology Drug Market Overview………………………………………………….
A. Market Size
2. Market Growth Drivers…………………………………………………………………
A. Rising Incidence of Cancer Cases in Kenya
B. Increased Awareness for Early Detection and Screening
C. Increase and Improvement in Diagnostic Capabilities
3. Epidemiology……………………………………………………………………………
A. Prevalence of Cancer Cases
B. Incidence of Cancer Cases
4. Oncology Drug Market Segmentation…………………………………………………..
A. Indication
I. Breast Cancer
II. Cervix-Uteri Cancer
III. Prostate Cancer
IV. Lung Cancer
V. Oesophagus Cancer
VI. Stomach Cancer
VII. Colorectal Cancer
VIII. Ovarian Cancer
IX. Non-Hodgkin Lymphoma
X. Others
B. Drug Class
I. Chemotherapy
II. Immunotherapy
III. Targeted Therapy
IV. Hormone Therapy
V. Others
C. Distribution Channels
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online
IV. Others
5. Oncology Major Products Market Share……………………………………………
A. Key Findings
B. Market Analysis, Insights and Forecast – By Drug Type
6. Competitive Landscape………………………………………………………..………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles……………………………………………………………….
A. Johnson & Johnson Company overview, Product & Services, Strategies & Financials
B. Eli-Lilly Company overview, Product & Services, Strategies & Financials
C. Novartis Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………
A. New Trends and Development of Oncology drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Indication:

On the basis of Indication, the Oncology Drug market can be segmented into Breast cancer, Cervix-Uteri cancer, Prostate cancer, Oesophagus cancer, Non-Hodgkin Lymphoma, colorectal cancer, Stomach cancer, Lung cancer, Blood cancer, ovarian cancer and other cancers.

According to Global Cancer Observatory, Breast Cancer is the most common type of cancer in Kenya, accounted for 16% of all cancer cases in 2020 in Kenya, followed by Cervical cancer (12.4%), Prostate cancer (8.1%), Oesophagus cancer (7.1%) and Colorectal cancer (6.5%).

By Drug Class:

On the basis of drug class, the Oncology Drug market can be segmented into Chemotherapy, Immunotherapy, Targeted Therapy and Hormone Therapy and other drug classes.

Immunotherapy is a type of cancer treatment that helps immune system of the body to fight cancer cells. Immunotherapy comprises of monoclonal antibodies, interferons and interleukins.

Immunotherapy and Targeted Therapy segment are anticipated to grow with the largest share in the market in the forecasted period owing to the identification of molecular targets of the cancer cells.

Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, are among the top selling Drug in Oncology Drug Market. Revlimid is a top selling oral immunomodulatory drug attacking the cancer cells by impacting on the immune system.

By Distribution Channels:

On the basis of distribution channel, the oncology Drug market can be segmented into Hospital pharmacies, retail pharmacies, online pharmacies and others.

Hospital pharmacies segment will see the fastest growth in the forecasted period and has the maximum market share.

Major Players

Key players in the oncology Drug market in Middle East and Africa region include Merck, Eli Lilly, Novartis, GSK, Johnson & Johnson, Amgen and Bristol Myers Squibb. Factors such as the high prevalence of cancer cases and the strong pipeline of Drug, will provide considerable growth opportunities to oncology drug manufactures.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements